Get started
Author

Valentina Eberlein

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
2021 · Dennis Lapuente, Jana Fuchs, et al. · Nature Communications · 228
PDF
Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication
2022 · Kim M. Stegmann, Antje Dickmanns, et al. · iScience · 44
PDF
A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model
2021 · Antonia Sophia Peter, Edith Roth, et al. · European Journal of Immunology · 39
PDF
Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2
2022 · Rüdiger Groß, Lívia Mesquita Dias Loiola, et al. · Advanced Science · 22
PDF
BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation
2021 · Stefanie Hoyer, Valentina Eberlein, et al. · International Journal of Molecular Sciences · 17
PDF
Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory Viruses
2022 · Tatjana Weil, Abbna Kirupakaran, et al. · JACS Au · 16
Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system
2023 · Philipp Reus, Hadar Guthmann, et al. · Journal of Controlled Release · 14
Mucosal Application of a Low-Energy Electron Inactivated Respiratory Syncytial Virus Vaccine Shows Protective Efficacy in an Animal Model
2023 · Valentina Eberlein, Mareike Ahrends, et al. · Viruses · 11
PDF
Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti‐SARS‐CoV‐2 Activity
2024 · Christian Gege, Friedrich Hahn, et al. · ChemMedChem · 10
PDF
Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias
2024 · Valentina Eberlein, Sophia Rosencrantz, et al. · Frontiers in Immunology · 10
Orally bioavailable RORγ/DHODH dual host-targeting small molecules with broad-spectrum antiviral activity
2024 · Alexandra Herrmann, Christian Gege, et al. · Antiviral Research · 8
Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2
2024 · Jannik T. Wagner, Sandra M. Müller-Schmucker, et al. · Communications Biology · 3
Adenoviral vector vaccines are effective mucosal booster modalities to elevate systemic and establish mucosal immunity against SARS-CoV-2
2023 · Dennis Lapuente, Vera Viherlehto, et al. · The Journal of Immunology · 2
PDF
DHODH Inhibitors Based on the Vidofludimus Scaffold Containing Carboxylic Acid Bioisosteres Exert a Superior Broad-Spectrum Antiviral Activity
2026 · Alexandra Herrmann, Friedrich Hahn, et al. · Journal of Medicinal Chemistry
Immunogenicity and protective efficacy of novel mucosal inactivated RSV vaccines
2024 · Eberlein, Valentina · Qucosa (Saxon State and University Library Dresden)
Author response for "A pair of non‐competing neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model"
2021 · Antonia Sophia Peter, Edith Roth, et al. · Publons reviews and discussion
Works count: 16
Citation count: 424
H-index: 10
I10-index: 10
Year
Topic
Type